What is the global market size of Spectral Computed Tomography Market?

Global Spectral Computed Tomography Market size was valued at USD 6.2 billion in 2021 and is poised to grow from USD 7.03 billion in 2022 to USD 10.93 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

Spectral Computed Tomography Market Size, Share, Growth Analysis, By Product(Spiral CT, Electron Beam Tomography, Multi-slice Computed Tomography, Positron Emission Tomography (Pet) and Single-photon Emission Computed Tomography), By Application(Oncology, Neurology, Cardiology, Vascular and Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2794 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 65 | Figures: 77

Spectral Computed Tomography Market News

In September 2022, Lumafield succeed in bagging $35 million through Series B funding. The funding would help the company to build affordable desktop CT scanners.
In September 2022, Sempre Group announced the launch of CT systems as well as industrial CT scanning and data analysis services from Ireland office
In September 2022, Auckland Radiology Group announced to build a new radiology clinic in Whangārei and Northland. The Facility will be equipped with PET CT scanner by mid-2023.
In September 2022, Austrailia launched new mobile cancer scan unit equipped with CT scanner for rural population

Spectral Computed Tomography Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spectral Computed Tomography Market size was valued at USD 7.03 billion in 2022 and is poised to grow from USD 7.49 billion in 2023 to USD 12.39 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The market demonstrates a moderate level of consolidation, where a few major players hold a substantial portion of the revenue share. These key industry participants are strategically focused on introducing innovative products to solidify their positions in the market. 'Siemens Healthineers', 'GE Healthcare', 'Philips Healthcare', 'Toshiba Medical Systems Corporation', 'Hitachi Medical Corporation', 'Shimadzu Corporation', 'Carestream Health', 'Samsung Medison', 'Hologic, Inc.', 'Fujifilm Medical Systems', 'Esaote SpA', 'Agfa-Gevaert Group', 'Mindray Medical International Limited', 'Planmed', 'CurveBeam LLC', 'Medtronic plc', 'Konica Minolta, Inc.', 'Varian Medical Systems', 'Analogic Corporation', 'NeuroLogica Corporation', 'Xoran Technologies, LLC', 'Cubresa Inc.'

The Spectral Computed Tomography (CT) market is witnessing significant growth, driven by the promise of enhanced diagnostic accuracy. Spectral CT technology goes beyond conventional CT scanning by capturing data at different energy levels, allowing for a more detailed analysis of tissue composition and material characterization. This advancement enables healthcare professionals to obtain comprehensive insights into the underlying properties of tissues, leading to improved detection and characterization of various medical conditions. The ability to differentiate between different materials based on their spectral signatures enhances diagnostic precision, particularly in complex cases where traditional CT imaging may fall short. By providing a more nuanced understanding of tissue composition, Spectral CT contributes to early and accurate diagnoses, ultimately improving patient outcomes and paving the way for more personalized and effective medical interventions.

The Spectral CT market has seen unexpected advancements, predominantly in reducing radiation doses. This progress aligns with the increasing importance of patient safety and minimizing radiation exposure in medical imaging procedures. Spectral CT technology introduces novelties like dual-energy imaging, which enables better tissue characterization and visualization while substantially lowering the radiation dose required for scans. By utilizing different energy spectra, spectral CT optimizes imaging protocols to fold more information with summary radiation exposure, making it an invaluable advancement in diagnostic imaging, particularly for susceptible populations or individuals demanding recurrent scans.

In 2021 North America held a commanding position, accounting for 30.4 % of the market and with no one able to challenge over the forecast period. This was due to several factors, such as the concentration of market competitors in a relatively small area and an increase in cancer rates. According to the National Cancer Institute, 1,806,590 cancer sufferers were diagnosed in the U.S. alone during that same year (2020). Furthermore, the arrival of cutting-edge technology which incorporates elements from artificial intelligence as well as frequent launches for low radiation CT scans promise to spur even greater market growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Spectral Computed Tomography Market News

Spectral Computed Tomography Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Spectral Computed Tomography Market?

Who are the key vendors in the Spectral Computed Tomography Market?

What is the key driver of Spectral Computed Tomography Market?

What is the key market trend for Spectral Computed Tomography Market?

Which region accounted for the largest share in Spectral Computed Tomography Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300